Jaemoon Lee, Yun Hee Lim, Sung Jun Hong, Jae Hun Jeong, Hey Ran Choi, Sun Kyung Park, Jung Eun Kim, Eun Hi Park, and Jae Hun Kim. Korean J Pain 2021;34:288-303. https://doi.org/10.3344/kjp.2021.34.3.288
Cho Long Kim, Sung Jun Hong, Yun Hee Lim, Jae Hun Jeong, Ho Sik Moon, Hey Ran Choi, Sun Kyung Park, Jung Eun Kim, Hakjong You, and Jae Hun Kim. Korean J Pain 2020;33:234-44. https://doi.org/10.3344/kjp.2020.33.3.234
6 April 2021 in ACS Pharmacology & Translational Science
Morphine is widely used in pain management although the risk of side effects is significant. The use of biased agonists to the G protein of μ-opioid receptors has been suggested as a potential solution, although oliceridine and PZM21 have previously failed to demonstrate benefits in clinical studies. An amplification-induced confusion in the process of comparing G protein and beta-arrestin pathways may account for previously biased agonist misidentification. Here, we have devised a strategy to discover biased agonists with intrinsic efficacy. We computationally simulated 430 000 molecular dockings to the μ-opioid receptor to construct a compound library. Hits were then verified experimentally. Using the verified compounds, we performed simulations to build a second library with a common scaffold and selected compounds that showed a bias to μ- and δ-opioid receptors in a cell-based assay. Three compounds (ID110460001, ID110460002, and ID110460003) with a dual-biased agonistic effect for μ- and δ-opioid receptors were identified. These candidates are full agonists for the μ-opioid receptor and show specific binding modes. On the basis of our findings, we expect our novel compounds to act as more biased agonists compared to existing drugs, including oliceridine.
Min Jung Kim, Ji Yeon Kim, Yun Hee Lim, Sung Jun Hong, Jae Hun Jeong, Hey Ran Choi, Sun Kyung Park, Jung Eun Kim, Min Ki Lee, and Jae Hun Kim. Korean J Pain 2022;35:475-87. https://doi.org/10.3344/kjp.2022.35.4.475
Background: Spinal epidural hematoma is rare condition that can rapidly develop into severe neurologic deficits. The pathophysiology of this development remains unclear. There are several case reports of emergency hematoma evacuations after epidural steroid injection. Case: We report on two patients who developed acute, large amounts of epidural hematoma without neurological deficits after transforaminal epidural steroid injection. After fluoroscopy guided aspiration for epidural hematoma was performed, neurological defects did not progress and the hematoma was shown to be absorbed on magnetic resonance imaging. Conclusions: These reports are believed to be the first of treating epidural hematoma occurring after transforaminal epidural steroid injection through non-surgical hematoma aspiration. If large amounts of epidural hematoma are not causing neurological issues, it can be aspirated until it is absorbed.
Bo-Mi Shin, Sung Jun Hong, Yun Hee Lim, Jae Hun Jeong, Ho Sik Moon, Hey Ran Choi, Sun Kyung Park, Richard Jin Woo Han, and Jae Hun Kim. Korean J Pain 2019;32:187-95. https://doi.org/10.3344/kjp.2019.32.3.187